Terms: = Lung cancer AND PALB2, ENSG00000083093, 79728 AND Treatment
10 results:
1. Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case report.
Zeng H; Tang X; Tian X; Liu Y; Tian P
Immunotherapy; 2023 Feb; 15(2):77-83. PubMed ID: 36695105
[TBL] [Abstract] [Full Text] [Related]
2. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
[TBL] [Abstract] [Full Text] [Related]
3. Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and palb2 in a Tumor-Only Genomic Testing Program.
Bychkovsky BL; Li T; Sotelo J; Tayob N; Mercado J; Gomy I; Chittenden A; Kane S; Stokes S; Hughes ME; Kim JS; Umeton R; Awad MM; Konstantinopoulos PA; Yurgelun MB; Wolpin BM; Taplin ME; Newmark RE; Johnson BE; Lindeman NI; MacConaill LE; Garber JE; Lin NU
Clin Cancer Res; 2022 Jun; 28(11):2349-2360. PubMed ID: 35363308
[TBL] [Abstract] [Full Text] [Related]
4. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K
Lancet Oncol; 2021 Sep; 22(9):1250-1264. PubMed ID: 34388386
[TBL] [Abstract] [Full Text] [Related]
5. Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell lung cancer: lung-MAP Substudy S1400G.
Owonikoko TK; Redman MW; Byers LA; Hirsch FR; Mack PC; Schwartz LH; Bradley JD; Stinchcombe TE; Leighl NB; Al Baghdadi T; Lara P; Miao J; Kelly K; Ramalingam SS; Herbst RS; Papadimitrakopoulou V; Gandara DR
Clin Lung Cancer; 2021 May; 22(3):187-194.e1. PubMed ID: 33583720
[TBL] [Abstract] [Full Text] [Related]
6. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or palb2 mutation.
Wattenberg MM; Asch D; Yu S; O'Dwyer PJ; Domchek SM; Nathanson KL; Rosen MA; Beatty GL; Siegelman ES; Reiss KA
Br J Cancer; 2020 Feb; 122(3):333-339. PubMed ID: 31787751
[TBL] [Abstract] [Full Text] [Related]
7. USP22 Interacts with palb2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks.
Nardi IK; Stark JM; Larsen A; Salgia R; Raz DJ
Mol Cancer Res; 2020 Mar; 18(3):424-435. PubMed ID: 31685642
[TBL] [Abstract] [Full Text] [Related]
8. Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.
Kadouri L; Rottenberg Y; Zick A; Hamburger T; Lipson D; Peretz T; Nechushtan H
Lung Cancer; 2019 Nov; 137():48-51. PubMed ID: 31542568
[TBL] [Abstract] [Full Text] [Related]
9. Identification of driver genes and somatic mutations in cell-free DNA of patients with pulmonary lymphangioleiomyomatosis.
Zhang L; Wang MJ; Wang W; Zhao JY; Wu JL; Liu YP; Zhu H; Qu JM; Zhou M
Int J Cancer; 2020 Jan; 146(1):103-114. PubMed ID: 31199508
[TBL] [Abstract] [Full Text] [Related]
10. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract] [Full Text] [Related]
